Most sites undercharge on research-paid items because no one reconciles the sponsor budget against the charge master. Here is ...

Forward Therapeutics' FT2109 advances to Phase 2 after clearing Phase 1 with once-daily oral dosing and a supportive safety ...

Headlands Research Portland site marks 50 years of continuous Alzheimer's trials, contributing to every FDA-approved ...

A pilot RCT links psilocybin's 25 mg dose to reduced egocentric bias in alcohol use disorder, exposing a blind spot in how ...

Advarra's IRB chief targets pre-review delays as the next efficiency frontier to reduce waiting time for researchers and trial participants.

First-in-human trial targets the amygdala with focused ultrasound in MDD, raising hard questions about biomarker selection, ...

Jon Himoff, Chief Product Officer of Image Analysis Group (IAG), on why purpose-built imaging platforms outperform assembled ...

Symphony RCT shows 55% closure rate in diabetic foot ulcers at 12 weeks, outperforming standard care alone with faster ...

Niia Signature Patch achieves 20-minute glucose signal recovery after insulin bolus, addressing a key challenge in all-in-one ...

Only 57% of clinical trial organizations have adopted the core components of risk-based quality management, according to a 2023 Tufts Center for the Study of Drug Development study, and a new ...

Mineralys presents Lorundrostat Phase 3 results from the Launch-HTN trial at ASN Kidney Week 2026, testing efficacy in ...

Lundbeck presents baseline enrollment data from Phase III MASCOT trial of amlenetug for multiple system atrophy, with ...